Early Age-Related HearingLoss Investigation (EARHLI) is a study to obtain information on how a hearing aid-based intervention can prevent cognitive decline in those at risk for Alzheimer's Disease and…
The purpose of this study is to learn more about the mechanisms of hearingloss, specifically to learn how abnormalities in the brain may produce certain experiences that are common in patients with hearing…
The CHORD clinical trial, sponsored by Decibel Therapeutics, is looking at the use of the gene therapy DB-OTO for children born with hearingloss related to changes in the OTOF gene. The goal of this trial is to assess different doses of DB-OTO to find out if it is safe, well-tolerated, and its…
Cisplatin is a chemotherapy medicine that is used to treat a variety of cancers. At high total (cumulative) doses it can be associated with progressive and irreversible hearingloss. The purpose of this study is see if injections of OTO-104 can protect against hearing…
The purpose of this research is to find out whether it is safe to use a virus to deliver a new gene to the inner ear of people with hearingloss. This is a kind of gene therapy which involves gene transfer. Once the genetic material…